Larsen; Finn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Larsen; Finn.The latest application filed is for "a method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent".

Company Profile

5.7.21

Larsen; Finn - Hawick GB
LARSEN; Finn - London GB
Larsen; Finn - Bonchester Bridge Hawich N/A GB
Larsen; Finn - Edinburgh GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition for treating one or more estrogen related diseases Grant 11,446,351 - Larsen , et al. September 20, 2	2022-09-20
A Method Of Preparing A Gelling Agent, The Gelling Agent Obtained Thereby, And The Use Of Said Gelling Agent App 20220023205 - Larsen; Finn ; et al.	2022-01-27
Gel Compositions for Transdermal Delivery to Maximize Drug Concentrations in the Stratum Corneum and Serum and Methods of Use Thereof App 20210338693 - BOLOGNA; William ; et al.	2021-11-04
A Reconstitutable Teverelix-tfa Composition App 20210236587 - Larsen; Finn ; et al.	2021-08-05
A Composition For Treating One Or More Estrogen Related Diseases App 20210052692 - LARSEN; Finn ; et al.	2021-02-25
Progesterone in Bioadhesive Formulation for Buccal Delivery App 20200129422 - Bologna; William ; et al.	2020-04-30
Composition For Treating Acute Urinary Retention App 20200129583 - LARSEN; Finn	2020-04-30
Compositions For Drug Delivery And Methods Of Use Thereof App 20200121589 - Bologna; William ; et al.	2020-04-23
A Composition Comprising At Least One Gnrh Antagonist App 20200000872 - LARSEN; Finn	2020-01-02
Combination Administration Of Gnrh Antagonists App 20180214506 - LARSEN; Finn	2018-08-02
Gel Compositions For Transdermal Delivery To Maximize Drug Concentrations In The Stratum Corneum And Serum And Methods Of Use Thereof App 20170196896 - BOLOGNA; William ; et al.	2017-07-13
Composition comprising at least one alginate for use in treatment and/or prevention of overweight Grant 9,597,350 - Larsen , et al. March 21, 2	2017-03-21
Composition Comprising At Least One Alginate For Use In Treatment And/or Prevention Of Overweight App 20160015736 - LARSEN; Finn ; et al.	2016-01-21
Solid pharmaceutical composition for neutralizing stomach acid Grant 9,186,409 - Larsen , et al. November 17, 2	2015-11-17
Composition comprising at least one alginate for use in treatment and/or prevention of overweight Grant 9,023,828 - Larsen , et al. May 5, 2	2015-05-05
Composition Comprising At Least One Alginate For Use In Treatment And/or Prevention Of Overweight App 20140128342 - Larsen; Finn ; et al.	2014-05-08
Solid Pharmaceutical Composition For Neutralizing Stomach Acid App 20130210762 - Larsen; Finn ; et al.	2013-08-15
Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds Grant 8,192,719 - Larsen June 5, 2	2012-06-05
Methods And Kits To Diagnose Growth Hormone Deficiency App 20090305300 - Larsen; Finn	2009-12-10
Effervescent Formulations Comprising Desmopressin App 20070218131 - Larsen; Finn	2007-09-20
Effervescent Formulations Of Oxytocin App 20070087054 - Larsen; Finn	2007-04-19
Effervescent Formulations Comprising Apomorphine App 20070071818 - Larsen; Finn	2007-03-29
Effervescent formulations comprising apomorphine App 20060141032 - Larsen; Finn	2006-06-29
Effervescent formulations of oxytocin App 20060034920 - Larsen; Finn	2006-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.